Filing Details

Accession Number:
0001209191-14-011292
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-18 16:16:33
Reporting Period:
2014-02-18
Filing Date:
2014-02-18
Accepted Time:
2014-02-18 16:16:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1125345 Macrogenics Inc MGNX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1211840 Edward Hurwitz C/O Macrogenics, Inc.
9640 Medical Center Drive
Rockville MD 20850
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-02-18 308,513 $36.50 1,704,996 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
Footnotes
  1. These securities were sold as follows: 282,573 by Alta BioPharma Partners III, L.P. ("ABP III"), 18,977 by Alta BioPharma Partners III LP GmbH ("ABP III KG") and 6,963 by Alta Embarcadero BioPharma Partners III, LLC ("AEBP III"). Edward Hurwitz is a director of Alta BioPharma Management Partners III, LLC, which is the general partner of ABP III, the managing limited partner of ABP III KG and the manager of AEBP III.
  2. The shares are held as follows: 1,561,635 by ABPIII; 104,877 by ABPIII KG; and 38,484 by AEBP III. Edward Hurwitz disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.